Literature DB >> 1376718

Production and characterization of two new mouse monoclonal antibodies reactive with denatured mouse class II beta chains.

K E LaPan1, D G Klapper, J A Frelinger.   

Abstract

We report on the production and characterization of two murine peptide specific anti-major histocompatibility complex class II chain specific monoclonal antibodies. Two new mouse monoclonal antibodies reactive with two synthetic peptides corresponding to Abb amino acids (146-157) and Abs amino acids (146-157) were produced. KL295 is the mouse anti-Abb monoclonal antibody, which reacts with denatured beta chains of H-2b, H-2d, H-2p, and H-2q, but fail to react with spleen cell lysates from H-2f, H-2j, H-2k and H-2s mice. The mouse anti Abs monoclonal antibody, KL304 in contrast reacts with the denatured Class II beta chains of H-2f, H-2j, H-2k and H-2s mice, but fails to bind H-2b, H-2d, H-2p or H-2q beta chain, suggesting residues 153-155 of this molecule to be critical for the epitope. Both KL295 and KL304 bind B10.WB (H-2j) which suggests a unique epitope in this strain of mice. Neither KL295 or KL304 react with native mouse class II cell surface molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376718     DOI: 10.1089/hyb.1992.11.217

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  3 in total

1.  Extracellular antigen processing and presentation by immature dendritic cells.

Authors:  L Santambrogio; A K Sato; G J Carven; S L Belyanskaya; J L Strominger; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Abundant empty class II MHC molecules on the surface of immature dendritic cells.

Authors:  L Santambrogio; A K Sato; F R Fischer; M E Dorf; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist.

Authors:  D M Ignar; J L Andrews; S M Witherspoon; J D Leray; W C Clay; K Kilpatrick; J Onori; T Kost; D L Emerson
Journal:  Clin Exp Metastasis       Date:  1998-01       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.